Company:  ATRICURE, INC. (ATRC)
Form Type:  4
Filing Date:  2/16/2012 
CIK:  0001323885 
Address:  6217 CENTRE PARK DRIVE 
City, State, Zip:  WEST CHESTER, Ohio 45069 
Telephone:  513-755-4107 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$15.26  
Change: 
0.01 (0.07%)  
Trade Time: 
Oct 24  
Market Cap: 
$419.21M
Description of Business
We are a medical device company providing innovative atrial fibrillation (�Afib�) solutions designed to produce superior outcomes that reduce the economic and social burden of atrial fibrillation. Our Synergy Ablation System (�Synergy System�) is the first and only device approved by the United States Food and Drug Administration (�FDA�) for the treatment of persistent and long-standing persistent forms of Afib in patients undergoing certain open concomitant procedures. We have two primary product lines for the ablation of cardiac tissue. Our primary product line for the ablation of cardiac tissue, which accounts for a majority of our revenue, is the Synergy System, a bipolar ablation clamp system and related radio frequency (�RF�) ablation devices. We also offer a cryoablation product line, which features reusable and disposable cryoablation devices.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES